Invesco
PMVP icon

Invesco’s PMV Pharmaceuticals PMVP Stock Holding History

Invesco’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,315
Closed -$19.2K – 3951
2024
Q1 		$19.2K Sell
11,315
-671
-6% -$1.25K ﹤0.01% 3839
2023
Q4 		$37.2K Buy
+11,986
New +$31.7K ﹤0.01% 3776
2023
Q1 		– Sell
-10,800
Closed -$94K – 3978
2022
Q4 		$94K Sell
10,800
-62
-0.6% -$661 ﹤0.01% 3838
2022
Q3 		$129K Sell
10,862
-88
-0.8% -$1.27K ﹤0.01% 3790
2022
Q2 		$157K Sell
10,950
-152
-1% -$2.21K ﹤0.01% 3792
2022
Q1 		$231K Buy
11,102
+285
+3% +$5.03K ﹤0.01% 3740
2021
Q4 		$249K Sell
10,817
-161,909
-94% -$3.91M ﹤0.01% 3698
2021
Q3 		$5.15M Sell
172,726
-44,538
-20% -$1.42M ﹤0.01% 2373
2021
Q2 		$7.42M Sell
217,264
-23,655
-10% -$790K ﹤0.01% 2235
2021
Q1 		$7.92M Sell
240,919
-65,590
-21% -$2.59M ﹤0.01% 2099
2020
Q4 		$18.9M Sell
306,509
-93,491
-23% -$3.67M 0.01% 1462
2020
Q3 		$14.2M Buy
+400,000
New +$14.7M ﹤0.01% 1481

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Invesco's PMVP Position: Q2 2024 in Review

Invesco sold out of PMV Pharmaceuticals (PMVP) in Q2 2024, closing a stake of 11,315 shares — an estimated $19.2K sold.

Invesco first reported a position in PMVP in Q3 2020 and held it in 12 quarters. The position peaked at $18.9M in Q4 2020. 93 funds tracked by Wall St. Rank hold PMVP as of Q2 2024.

  • Invesco reported no remaining PMV Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Invesco sold 11,315 PMV Pharmaceuticals shares in Q2 2024, an estimated $19.2K.
  • Invesco first reported a position in PMV Pharmaceuticals in Q3 2020 and held it in 12 quarters.
  • Invesco's PMV Pharmaceuticals position peaked at $18.9M in Q4 2020.
  • 93 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2024.

Based on Invesco's 13F filing for Q2 2024, filed 13 Aug 2024.